Chemung Financial (CMHG) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual shareholder meeting scheduled for June 3, 2025, to be held virtually.
Proxy materials, including the annual report and proxy statement, are available online for review before voting.
Voting matters and shareholder proposals
Election of four directors: Ronald M. Bentley, David M. Buicko, Robert H. Dalrymple, and Jeffrey B. Streeter.
Advisory vote to approve compensation of Named Executive Officers (Say-on-Pay).
Approval of the 2025 Equity Incentive Plan.
Ratification of Crowe LLP as independent registered public accounting firm for fiscal year ending December 31, 2025.
Board of directors and corporate governance
Director nominees listed for election at the annual meeting.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Chemung Financial
- All proposals passed; strong 2023 results, expansion, and dividends highlighted.CMHG
AGM 202431 Jan 2026 - Annual non-GAAP net income rose 17.8% to $27.9M, driven by strong loan growth and margin gains.CMHG
Q4 202526 Jan 2026 - Board recommends FOR all proposals, including director elections and new equity plan.CMHG
Proxy Filing2 Dec 2025 - All proposals, including director elections and compensation, were approved by majority vote.CMHG
AGM 202526 Nov 2025 - Q3 net income up 36% year-over-year, with strong loan growth and improved margins.CMHG
Q3 20256 Nov 2025 - Net income declined 21% year-over-year as margin pressure persisted, but capital and lending improved.CMHG
Q2 20249 Oct 2025 - Adjusted net income reached $6.3M as capital moves offset a $17.5M securities loss.CMHG
Q2 20257 Aug 2025 - Q3 2024 net income fell year-over-year as higher costs offset loan growth and margin stability.CMHG
Q3 202413 Jun 2025 - 2024 net income fell 5.3% to $23.7M as higher expenses offset loan growth.CMHG
Q4 20249 Jun 2025